ESR1 and breast cancer: Furthermore, the prognostic value of both ESR1 and HSF1 was visible in such homogenous groups (Figure 6—figure supplement 1C), which may simply reflect the prognostic difference between the basal-like and luminal A (i.e., ER-negative and ER-positive) breast cancer subtypes.